UCLA and PreciseDx Collaborate on AI-Powered Breast Cancer Recurrence Diagnostics
This collaborative study seeks to represent a significant step forward in digital pathology and oncology breast cancer research
Category: Breast
Breast
Latest
Breast
Latest
Reveal Genomics Details Success of Liquid Biopsy Test for Metastatic Breast Cancer
DNADX utilizes sequencing DNA data from tumor tissue or plasma circulating tumor DNA to classify breast cancer into four subtypes or clusters.
Breast
Latest
Breast Cancer Overdiagnosis Common Among Older Women
New findings suggest that overdiagnosis may be common among older women who are diagnosed with breast cancer after screening.
FDA Approves Guardant Health’s CDx Liquid Biopsy for Breast Cancer Patients
The FDA approved the Guardant360 CDx liquid biopsy test as a companion diagnostic for metastatic breast cancer patients with ESR1 mutations.
Read More
Scientists Find New Marker that Predicts Early Breast Cancer Recurrence
Scientists found a marker to identify patients with estrogen receptor-positive breast cancer who may benefit from new immunotherapies.
Read More
PreciseDx AI Platform Predicts Early-Stage Breast Cancer Recurrence
PreciseDx detailed its digital AI platform, which designed to enrich breast cancer grading and improve risk categorization.
Read More
Immune System B-cells Can Help Predict HER2-Positive Breast Cancer Treatment Response
Measuring activation of immune-system B cells may be an ideal method in predicting whether HER2-positive breast cancer responds to treatment.
Read More
Genetic Profiling May Identify Breast Cancer Patients Who Can Omit Radiation Therapy
Breast cancer patients who undergo breast-conserving surgery are recommended to do adjuvant radiation therapy to reduce local recurrence risk.
Read More
RNA-Based Liquid Biopsy Platform Detects Early-Stage Breast Cancer
Researchers released data demonstrating that an RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages.
Read More
Breast Cancer Index Test Predicts Treatment Benefit
Hologic, Inc. has released new study data showing that the Breast Cancer Index test identified which patients benefited from therapy.
Read More
MicroRNAs Can Help Predict Disease Recurrence in Breast Cancer Patients
Researchers have determined that microRNAs can help predict which patients with breast cancer are likely to face a recurrence of the disease.
Read More
Newly Developed Gene Classifier Identifies Risk of Breast Pre-Cancer Progression
A team of researchers made a major advance toward distinguishing if early pre-cancers in the breast will progress into invasive cancers.
Read More
Researchers Find Changes in Blood Proteins Years Before Breast Cancer Diagnosis
Researchers found changes in the levels of particular proteins in people’s blood up to two years prior to a breast cancer diagnosis.
Read More
Breast Cancer Spread Uncovered by New Molecular Microscopy
New technology can trace which populations of breast cancer cells are responsible for the spread of the disease.
Read More
MicroRNA as Biomarker Can Help Predict Breast Cancer Recurrence
MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality.
Read More
Cancer Diagnoses Continue to Lag During Pandemic
More than two years after the COVID-19 pandemic began, cancer diagnoses continue to lag behind pre-pandemic levels.
Read More
A Next-Gen Liquid Biopsy Detects Signs of Breast Cancer in Early-Stages, USC Study Finds
Scientists found indications that a liquid biopsy could determine whether a patient has breast cancer at its early stage.
Read More
Clinical Practice Guidelines Recommend Genetic Testing for Those with Breast Cancer
Invitae released a study recommending genetic testing for those with breast cancer, and showing how testing improves patient outcomes.
Read More